Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Jounce Therapeutics Inc. (JNCE)

6.31   -0.22 (-3.37%) 01-24 16:00
Open: 6.58 Pre. Close: 6.53
High: 6.5953 Low: 6.15
Volume: 402,163 Market Cap: 210M
Jounce Therapeutics Inc is a clinical stage immunotherapy company. It is engaged in transforming the treatment pf cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.643 - 6.707 6.707 - 6.745
Low: 6.02 - 6.1 6.1 - 6.148
Close: 6.217 - 6.349 6.349 - 6.429

Technical analysis

as of: 2020-01-24 4:33:12 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 9.95     One year: 11.68
Support: Support1: 6.11    Support2: 5.09
Resistance: Resistance1: 8.52    Resistance2: 10.00
Pivot: 7.39
Moving Average: MA(5): 6.83     MA(20): 7.68
MA(100): 5.36     MA(250): 5.10
MACD: MACD(12,26): -0.21     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 9.60     %D(3): 12.33
RSI: RSI(14): 35.18
52-week: High: 10.00  Low: 2.79  Change(%): 84.0
Average Vol(K): 3-Month: 76429  10-Days: 44960

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
JNCE has closed below the lower band by 3.2%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 14% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-12-20
Is Jounce Therapeutics (JNCE) Stock Outpacing Its Medical Peers This Year?
Is (JNCE) Outperforming Other Medical Stocks This Year?

2019-12-05
Is the Options Market Predicting a Spike in Jounce Therapeutics (JNCE) Stock?
Investors need to pay close attention to Jounce Therapeutics (JNCE) stock based on the movements in the options market lately.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33.23
Shares Float (M) 16.16
% Held by Insiders 12.74
% Held by Institutions 71.31
Shares Short (K) 851
Shares Short P. Month (K)

Stock Financials

EPS 2.290
Book Value (p.s.) 5.760
PEG Ratio
Profit Margin 46.11
Operating Margin 43.58
Return on Assets (ttm) 20.0
Return on Equity (ttm) 52.5
Qtrly Rev. Growth 722.2
Gross Profit (p.s.) 1.033
Sales Per Share
EBITDA (p.s.) 2.319
Qtrly Earnings Growth
Operating Cash Flow (M) -30.97
Levered Free Cash Flow (M) -3.72

Stock Valuations

P/E 2.76
P/E Growth Ratio -0.03
P/BV 1.10
P/S 1.23
P/CF -6.77

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.